Skip to content

Ethos daily replanning improves tumor coverage in Malaysia's review

Malaysia's MaHTAS found moderate-quality evidence in 10 observational studies that Ethos adaptive radiotherapy improves tumor coverage and organ sparing in the short term.

  • 2 for a person

    Patients in the reviewed studies received better target coverage and, in most studies, lower doses to nearby organs, though no study reported tumor control, survival or long-term toxicity.

Depth runs from 1, a convenience or time saved, to 5, a life or a livelihood preserved.

Status
Reported benefit.
Evidence

found, the grade of this recordstudiedreportedclaimed

An independent assessment report supports the benefit.

Compared with

The scheduled (non-adaptive) plans for the same fractions, in one study of 11 prostate cancer patients in the Netherlands. Measured.

Without the system
86.7% ± 6.2% coverage of the PTV60Gy with the scheduled plan
With it
99.4% ± 0.5% with the adapted plan
The system’s part
Not isolated. The studies compared plans adapted on Ethos with the scheduled plans for the same fractions, so the gain belongs to daily adaptation as a whole. MaHTAS does not separate the AI's contouring and planning from the daily cone-beam CT imaging and the clinicians' edits. It writes that the platform is based on convolutional neural networks.
Not yet checked
LimitsCosts and harmsLearns from dataLater outcome
Benefit type
Improved Task Accuracy
System
Ethos therapy (Varian Ethos online adaptive radiotherapy)
Made by
Varian Medical Systems (a Siemens Healthineers company)
Used by
Several radiotherapy centers in the 10 studies that MaHTAS reviewed, among them University Hospital Essen, UT Southwestern Medical Center, Rigshospitalet and Medisch Spectrum Twente
Where
Germany, the Netherlands, Denmark, the United States, Australia and China (studies that MaHTAS reviewed)
Stage
In routine use
Date
, when the source was published
Kind
Aggregate result
Broad benefit
Identifying Objects, Actions, and Events, Drafting, Laying Out, and Specifying Technical Devices, Parts, and Equipment
Collections
Scrutiny and findings, Cross-border records
Last revised
1 November 2026

Sources

  1. Assessment report, by authors with no tie to the system.

    Malaysian Health Technology Assessment Section (MaHTAS), Medical Development Division, Ministry of Health Malaysia. Ethos Therapy for Cancer Patient. Technology Review (Mini-HTA), Report No. 012/2024. 2024. Executive summary, results and conclusion on effectiveness. Archived copy of 21 January 2026.

    There was moderate quality evidence showing that online adaptive radiotherapy (oART) may improve target coverage while reducing normal tissue exposure, palpable by superior dosimetric benefits in many observational studies.
    There is moderate quality of evidence from observational studies showing that online adaptive radiotherapy (oART) improves short-term dosimetric outcomes, such as target coverage and organ sparing, in patients with head and neck, lung, bone metastases, and pelvic cancer.

Details

AI system

Workflow

Convolutional neural networks outlined the main anatomical structures on each day's cone-beam CT scan. An optimization engine generated an adapted plan, and clinicians chose between it and the scheduled plan while the patient stayed on the couch. Clinicians reviewed and edited the AI contours before treatment.

Follow-up

Conditions for replication

A radiation oncologist, physicist, dosimetrist and therapist are available during each session. Staff are trained to edit and validate AI contours. Patients are selected with care, since the gain may be larger in anatomically complex sites such as the pelvis and bladder. The AI contouring is trained on data that represent the local population.

Entry details

Sector

Healthcare.

Purpose

Varian Medical Systems built Ethos therapy to adapt radiotherapy plans to each day's anatomy, using AI contouring and automated planning while the patient lies on the treatment couch.

31 more questions not yet checked

model, release, provider, role, configuration, inputs and outputs, autonomy, human oversight, AI contribution, beneficiaries, reach, distribution and access, duration, every measurement question, every money question, ownership and control, dependencies, cross-border connections, geopolitical implications, replication attempts, availability, institutional decision, grounds, action and result, success criterion, every evidence question, observed or intended, alternative assessments, related entries, other identifiers, category mappings.

Cite this record

Peter H. Vartanian. (2026). Ethos daily replanning improves tumor coverage in Malaysia's review (AIBD-1095). Artificial Intelligence Benefits Database, edition of 1 November 2026. https://petervartanian.xyz/aibd/records/AIBD-1095.html (archived at https://doi.org/10.7910/DVN/AADSII, version 7.0)

BibTeX Data Field definitions